Skip to main navigation Skip to search Skip to main content

Hypermethylation of the p16 gene in sporadic T3NOMO stage colorectal cancers: Association with DNA replication error and shorter survival

  • Jin Tung Liang
  • , King Jen Chang*
  • , Jeng Chang Chen
  • , Chun Chung Lee
  • , Yung Ming Cheng
  • , Hey Chi Hsu
  • , Ming Shiang Wu
  • , Shih Ming Wang
  • , Jaw Town Lin
  • , Ann Lii Cheng
  • *Corresponding author for this work
  • National Taiwan University

Research output: Contribution to journal › Journal Article › peer-review

79 Scopus citations

Abstract

Hypermethylation in the promoter region of the p16 gene was suspected to be involved in the tumorigenesis of colorectal cancers, although its clinical and biological significance remains obscure. In this study, we collected 84 T3NOMO stage primary colorectal cancers that were curatively resected. The clinicopathologic data were reviewed. p16 hypermethylation was determined by a methylation-specific polymerase chain reaction (PCR). p53 overexpression was detected by immunocytochemistry (ICC). The point mutations in the 12 and 13 codons of the K-ras gene were screened by restriction enzyme analysis. Loss of heterozygosity (LOH) of the DCC (Deleted in Colorectal cancer) gene was examined by PCR using primers of the DCC (18q21) microsatellite marker. The DNA replication error (RER) was examined using 7 microsatellite markers at distinct chromosomal loci. p16 hypermethylation, regarded as an indication of p16 inactivation, was evident in 24 (28.6%) of the tumors. No correlation was found between p16 hypermethylation and various clinicopathologic factors, includinig age, sex, tumor location, tumor size, growth pattern, tumor differentiation, mucin production, vascular and/or lymphatic invasion, lymphocyte infiltration of the tumor, and serum level of carcinoembryonic antigen. There was no association between p16 hypermethylation of K-ras gene mutation, p53 overexpression and LOH of the DCC gene. However, p16 hypermethylation was significantly associated with DNA RER (p = 0.01). Survival analysis revealed a significant survival disadvantage of p16-hypermethylated versus non-p16-hypermethylated tumors (p = 0.0001). These findings indicate that p16 hypermethylation plays a role in the carcinogenesis of a subset of colorectal cancers; and the presence of p16 hypermethylation predicts shorter survival in T3NOMO stage colorectal cancers.

Original languageEnglish
Pages (from-to)149-156
Number of pages8
JournalOncology
Volume57
Issue number2
DOIs
StatePublished - 08 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CDKN2A
  • Colorectal cancers
  • MTS1
  • Mehtylation-specific PCR
  • Methylation
  • p16
  • p16INK4a

Fingerprint

Dive into the research topics of 'Hypermethylation of the p16 gene in sporadic T3NOMO stage colorectal cancers: Association with DNA replication error and shorter survival'. Together they form a unique fingerprint.

Cite this